Literature DB >> 6812426

Oculocutaneous albinoidism as a manifestation of reduced neural crest derivatives in the Prader-Willi syndrome.

H M Hittner, R A King, V M Riccardi, D H Ledbetter, R P Borda, R E Ferrell, F L Kretzer.   

Abstract

Nine patients with Prader-Willi syndrome (five female and four male; one Oriental and eight white), all of whom had interstitial deletions of the proximal long arm of one chromosome 15 (q11-q13) were found to have decreased tyrosinase activity in isolated hair bulbs. As infants, all patients had light hair and skin coloring, both of which darkened with age. Light and electron microscopic analysis of skin and hair bulbs disclosed a reduced number of melanocytes in the basal epidermis and hair bulbs. Each patient demonstrated decreased pigmentation of the iris stroma, which was accentuated peripherally and manifested clinically as iris translucency. There was no foveal hypoplasia, nystagmus, or photophobia, and ocular function was normal. Oculocutaneous albinoidism is thus a component of del(15q) Prader-Willi syndrome with reduction of melanocytes of neural crest origin (skin, hair, and iris stroma) and retention of normal retinal and iris pigment epithelia of neuroectodermal origin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812426     DOI: 10.1016/0002-9394(82)90358-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  The p locus is closely linked to the mouse homolog of a gene from the Prader-Willi chromosomal region.

Authors:  Y Nakatsu; Y Gondo; M H Brilliant
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12.

Authors:  M Ramsay; M A Colman; G Stevens; E Zwane; J Kromberg; M Farrall; T Jenkins
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

3.  The association of Angelman's syndrome with deletions within 15q11-13.

Authors:  M Pembrey; S J Fennell; J van den Berghe; M Fitchett; D Summers; L Butler; C Clarke; M Griffiths; E Thompson; M Super
Journal:  J Med Genet       Date:  1989-02       Impact factor: 6.318

4.  Synchrony of oculocutaneous albinism, the Prader-Willi syndrome, and a normal karyotype.

Authors:  C E Wallis; P H Beighton
Journal:  J Med Genet       Date:  1989-05       Impact factor: 6.318

5.  Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome.

Authors:  M G Butler; F J Meaney; C G Palmer
Journal:  Am J Med Genet       Date:  1986-03

Review 6.  The mouse pink-eyed dilution locus: a model for aspects of Prader-Willi syndrome, Angelman syndrome, and a form of hypomelanosis of Ito.

Authors:  M H Brilliant
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

7.  AMINO ACID LEVELS IN PRADER-WILLI SYNDROME AND OBESE INDIVIDUALS.

Authors:  Merlin G Butler; Joel E Murrell; Harry L Greene
Journal:  Dysmorphol Clin Genet       Date:  1990

8.  Hypopigmentation: a common feature of Prader-Labhart-Willi syndrome.

Authors:  M G Butler
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

9.  Hypopigmentation in the Prader-Willi syndrome.

Authors:  G L Wiesner; C M Bendel; D P Olds; J G White; D C Arthur; D W Ball; R A King
Journal:  Am J Hum Genet       Date:  1987-05       Impact factor: 11.025

10.  Visual evoked potentials in Prader-Willi syndrome.

Authors:  P Apkarian; H Spekreijse; E van Swaay; M van Schooneveld
Journal:  Doc Ophthalmol       Date:  1989-04       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.